Revisiting risk and benefit in early oncology trials in the era of precision medicine: A systematic review and meta-analysis of phase i trials of targeted single-agent anticancer therapies

Michael P. Mackley, Nicholas R. Fernandez, Benjamin Fletcher, Christy G. Woolcott, Conrad V. Fernandez

Research output: Contribution to journal › Review article › peer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Revisiting risk and benefit in early oncology trials in the era of precision medicine: A systematic review and meta-analysis of phase i trials of targeted single-agent anticancer therapies'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry